Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06564389
What this trial is testing

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Who this might be right for
Healthy ParticipantsAtopic Dermatitis
Pfizer 119
Early research (Phase 1)Study completedNCT04544943
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Hoth Therapeutics, Inc. 31
Early research (Phase 1)Study completedNCT04612062
What this trial is testing

A First-in-Human Study of CEE321 in Adult Subjects

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 28
Early research (Phase 1)Ended earlyNCT06119529
What this trial is testing

LY3872386 in Healthy Participants and Participants With Atopic Dermatitis

Who this might be right for
HealthyAtopic Dermatitis
Eli Lilly and Company 18
Early research (Phase 1)Study completedNCT07172321
What this trial is testing

Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults

Who this might be right for
Atopic Dermatitis
Pfizer 12
Early research (Phase 1)Ended earlyNCT03689829
What this trial is testing

Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
HealthyAtopic Dermatitis
Lakefront Biotherapeutics NV 44
Testing effectiveness (Phase 2)Study completedNCT04643457
What this trial is testing

Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
UCB Biopharma SRL 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782476
What this trial is testing

Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Health Adult SubjectsAtopic Dermatitis (AD)
Helixon Biotechnology (Suzhou) Co., Ltd 67
Not applicableNot Yet RecruitingNCT07549828
What this trial is testing

Sebum Metabolomics and Lipidomics for Clinical Applications

Who this might be right for
AcneAtopic DermatitisSeborrheic Dermatitis+2 more
National Taiwan University Hospital 200
Early research (Phase 1)Study completedNCT06553209
What this trial is testing

Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 110
Early research (Phase 1)Study completedNCT05945810
What this trial is testing

Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects

Who this might be right for
Atopic Dermatitis
Hangzhou Highlightll Pharmaceutical Co., Ltd 28
Early research (Phase 1)Ended earlyNCT04444466
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants

Who this might be right for
Healthy Study ParticipantsChronic Spontaneous Urticaria
UCB Biopharma SRL 40
Early research (Phase 1)Looking for participantsNCT07604324
What this trial is testing

A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Novartis Pharmaceuticals 63
Not applicableStudy completedNCT04295824
What this trial is testing

Skin Pathology Assessment With Optical Technologies

Who this might be right for
Atopic Dermatitis Eczema
Sheffield Teaching Hospitals NHS Foundation Trust 80
Early research (Phase 1)Study completedNCT07190430
What this trial is testing

Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants

Who this might be right for
Atopic Dermatitis
Pfizer 16
Early research (Phase 1)Study completedNCT05170243
What this trial is testing

A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection

Who this might be right for
AsthmaCOPDAtopic Dermatitis
Mabwell (Shanghai) Bioscience Co., Ltd. 28
Not applicableStudy completedNCT07017348
What this trial is testing

Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic Dermatitis

Who this might be right for
Atopic DermatitisHealthy
Pierre Fabre Dermo Cosmetique 50
Early research (Phase 1)Study completedNCT06438263
What this trial is testing

Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

Who this might be right for
Atopic Dermatitis
Amgen 231
Early research (Phase 1)Looking for participantsNCT07800104
What this trial is testing

Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
QuantX Biosciences, Inc. 84
Early research (Phase 1)Study completedNCT07466940
What this trial is testing

A Clinical Study to Evaluate SM17 in Healthy Participants

Who this might be right for
Atopic DermatitisAsthmaInflammatory Bowel Disease
SinoMab BioScience Ltd 30
Next Page